Osteopontin splice variants and polymorphisms in cancer progression and prognosis.

Biochim Biophys Acta Rev Cancer

Regeneration and Repair, Institute of Hepatology, Foundation for Liver Research, London, United Kingdom; Division of Gastroenterology and Hepatology, Department of Medicine, Medical University of South Carolina, Charleston, SC., United States; Section of Gastroenterology, Ralph H Johnson Veteran Affairs Medical Center, Charleston, SC, United States. Electronic address:

Published: August 2017

Osteopontin (OPN) is an extracellular matrix protein that is overexpressed in various cancers and promotes oncogenic features including cell proliferation, survival, migration, and angiogenesis, among others. OPN can participate in the regulation of the tumor microenvironment, affecting both cancer and neighboring cells. Here, we review the roles of OPN splice variants (a, b, c) in cancer development, progression, and prognosis, and also discuss the identities of isoforms 4 and 5. We also discussed how single-nucleotide polymorphisms (SNPs) of the OPN gene are an additional factor influencing the level of OPN in individuals, modulating the risks of cancer development and outcome.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbcan.2017.02.005DOI Listing

Publication Analysis

Top Keywords

splice variants
8
progression prognosis
8
cancer development
8
opn
5
osteopontin splice
4
variants polymorphisms
4
cancer
4
polymorphisms cancer
4
cancer progression
4
prognosis osteopontin
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!